Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
India Glycols Limited ( (IN:INDIAGLYCO) ) has provided an update.
India Glycols Limited has reported that the National Company Law Tribunal, Allahabad Bench at Prayagraj, has admitted the second motion petition for its Scheme of Arrangement among India Glycols, Ennature Biopharma Limited and IGL Spirits Limited. The scheme, pursued under Sections 230 to 232 of the Companies Act, aims to reorganize the company and its resulting entities, potentially sharpening business focus across chemicals, biopharma and spirits.
Following the Tribunal’s order dated 9 April 2026, the company has been directed to publish notices in newspapers and issue notices to specified statutory authorities, inviting any representations within 30 days. The matter is scheduled for further hearing on 21 May 2026, and the scheme remains subject to regulatory and other approvals, leaving final implications for shareholders and creditors contingent on the completion of the approval process.
More about India Glycols Limited
India Glycols Limited operates in the chemicals and bio-based products industry, with activities spanning specialty chemicals, pharmaceuticals-related ingredients and spirits through its group entities. The company serves industrial customers in India and abroad, and is restructuring certain businesses via court-approved schemes of arrangement to optimize its corporate structure and focus areas.
Average Trading Volume: 7,001
Technical Sentiment Signal: Buy
Current Market Cap: 60.4B INR
For detailed information about INDIAGLYCO stock, go to TipRanks’ Stock Analysis page.